Cargando…
The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer
BACKGROUND: Breast cancer is a highly heterogeneous disease. Early-stage, non-metastatic breast cancer is considered curable after definitive treatment. Early detection of tumor recurrence and metastasis through sensitive biomarkers is helpful for guiding clinical decision-making and early intervent...
Autores principales: | Yang, Yang, Zhang, Jie, Li, Jiao-Yang, Xu, Lu, Wang, Si-Ning, Zhang, Jun-Qi, Xun, Zhou, Xia, Yu, Cao, Jian-Bo, Liu, Yang, Shi, Li-Yan, Li, Wei, Shi, Yong-Lei, He, Yuan-Ge, Gu, De-Jian, Yu, Zheng-Yuan, Chen, Kai, Lan, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840987/ https://www.ncbi.nlm.nih.gov/pubmed/36654951 http://dx.doi.org/10.21037/gs-22-634 |
Ejemplares similares
-
Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer——A retrospective study of ctDNA
por: Zhang, Xuefei, et al.
Publicado: (2023) -
Current status of ctDNA in precision oncology for hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2021) -
The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma
por: Ding, Yubo, et al.
Publicado: (2022) -
Next-Generation Sequencing Analysis of ctDNA for the Detection of Glioma and Metastatic Brain Tumors in Adults
por: Liang, Jianfeng, et al.
Publicado: (2020) -
Comparison of the SuperARMS and Droplet Digital PCR for Detecting EGFR Mutation in ctDNA From NSCLC Patients
por: Feng, Wei-neng, et al.
Publicado: (2018)